Swiss stocks extended their gains to a third day, with the Swiss Market Index up 1.49% on Wednesday's close, as investors assessed a fresh batch of corporate and economic updates.
Data from UBS & CFA Society Switzerland showed that the country's economic sentiment index plunged to -25 points in June from -11.1 points in May.
On the defense front, the Swiss Federal Council reduced the planned temporary increase in the standard rate for value-added tax to 0.5 percentage points from 0.8 percentage points. The revenue generated from the VAT increase will be earmarked for military defense spending for a period of 12 years instead of the previous 10.
The council also said it will resume payments to the US for the Patriot missile systems to advance the project with minimal delay and prevent jeopardizing other procurements from the US, including the F-35A fighter jet. Meanwhile, the Federal Department of Defence, Civil Protection and Sport will begin contract negotiations with manufacturers from France, Israel, and South Korea for a second long-range, ground-based air defense system.
In corporate news, AlphaValue/Baader Europe confirmed its buy rating on OC Oerlikon (OERL.SW), with a price target of 4.86 francs, as it raised its second-quarter organic sales growth forecast to 5.3% from 2.1% amid price increases on the back of material surcharges. The Swiss surface technologies and advanced materials company's shares gained 3.95% at closing.
"For the full year, we have only raised our Adj. EBITDA margin forecast to 17.7% from 17.2%, as we expect the opposite effect in H2 for inventory revaluation. However, this impact should be more limited, as the group is now reducing its inventory levels. We believe the company will benefit from this situation. H1 results should act as a catalyst," the research firm said in a note.
Eli Lilly (LLY.SW) completed its purchase of clinical-stage company Centessa Pharmaceuticals, which develops a new class of medicines to treat narcolepsy and other sleep-wake disorders.
On the geopolitical front, the US Senate approved a war powers resolution in a 50-48 vote seeking to curb President Donald Trump's ability to launch military action against Iran without congressional approval.